Literature DB >> 10985140

Pheochromocytoma. Special considerations in children.

J H Ross1.   

Abstract

Pheochromocytoma is a rare but important tumor in children. Appropriate evaluation and management are essential for a favorable outcome. Pheochromocytomas are more often multifocal and extra-adrenal in children when compared with adults. This pattern makes the diagnosis, localization, and surgical management more challenging. Nonetheless, the standard biochemical evaluation is usually diagnostic, and MR imaging is currently the best tool for tumor localization. The possibility of a familial syndrome must always be considered and should always be thoroughly evaluated when children present with a pheochromocytoma. Conversely, children with a familial syndrome should undergo annual screening for pheochromocytoma from a young age. Given the greater likelihood of a metachronous recurrence in children, consideration should be given to adrenal-sparing surgery in selected patients. When managed appropriately, the outlook for pheochromocytoma in children is excellent. Unfortunately, the uncommon malignant tumors are still difficult to treat. Perhaps the unique genetic characteristics of pheochromocytoma will ultimately be exploited in the management of the aggressive forms of this disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985140     DOI: 10.1016/s0094-0143(05)70088-4

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  22 in total

1.  Surgical analysis of pediatric and adolescent sporadic pheochromocytoma: single center experience.

Authors:  Yasser Osman; Naser Hussein; Osama Sarhan; Ahmed A Shorrab; Mohamed Dawaba; Mohamed A Ghoneim
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

2.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

3.  Metachronous occurrence of multifocal phaeochromocytoma.

Authors:  Vishesh Jain; Amit Bishnoi; Kanta Meena; Varun Aggarwal; Rajiv Chadha; Archana Puri; Subhasis Roy Choudhury
Journal:  Indian J Pediatr       Date:  2010-12-03       Impact factor: 1.967

4.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

5.  Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.

Authors:  Ivana Jochmanova; April Melody T Abcede; Ruby Jane S Guerrero; Chandy Lou P Malong; Robert Wesley; Thanh Huynh; Melissa K Gonzales; Katherine I Wolf; Abhishek Jha; Marianne Knue; Tamara Prodanov; Naris Nilubol; Leilani B Mercado-Asis; Constantine A Stratakis; Karel Pacak
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-15       Impact factor: 4.553

Review 6.  Update on pediatric pheochromocytoma.

Authors:  Bas Havekes; Johannes A Romijn; Graeme Eisenhofer; Karen Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

Review 7.  Urinary bladder pheochromocytoma, an extremely rare tumor in children: case report and review of the literature.

Authors:  J W C Mou; K H Lee; Y H Tam; S T Cheung; K W Chan; A Thakre
Journal:  Pediatr Surg Int       Date:  2007-09-09       Impact factor: 1.827

8.  Pheochromocytoma management, outcomes and the role of cortical preservation.

Authors:  Alisha Gupta; Sandeep Agarwala; Nikhil Tandon; M Srinivas; Minu Bajpai; Devendra Kumar Gupta; Arun Kumar Gupta; Chandersekhar Bal; Rakesh Kumar; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2013-11-08       Impact factor: 1.967

Review 9.  Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome.

Authors:  Karel Pacak; Graeme Eisenhofer; Ioannis Ilias
Journal:  Hormones (Athens)       Date:  2009 Apr-Jun       Impact factor: 2.885

10.  Experience with surgical excision in childhood pheochromocytoma.

Authors:  Hyun-Young Kim; Hye Seung Lee; Seung-Eun Jung; Seong-Cheol Lee; Kwi-Won Park; Woo-Ki Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.